This list may not describe all possible interactions
This shift is often what patients describe as the most meaningful change
Other times, it's because of lifestyle choices, like not eating well or not getting enough physical activity
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss. Diabetes Obes Metab
In her presentation, Caroline Geisler, Assistant Professor at the University of Kentucky College of Pharmacy, explained: For example, one study of about 9,000 matched individuals on tirzepatide or semaglutide found that after six months, non-diabetic patients had, on average, a 2% greater weight loss than those with type 2 diabetes
Semaglutide Have you been struggling to manage your weight